Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00688987 · ClinicalTrials.gov registry record · NA
The Hypothalamic-Pituitary-Adrenal (HPA) Axis as an Effector System in Weight Regulation
A NA study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT00688987 is a NA study that has completed, run by Oregon Health and Science University. The registered enrollment target is 24 participants.
The verdict
NCT00688987, a NA study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
Replacing glucocorticoid in a dose dependent manner (including doses within the physiological range) to subjects with adrenal insufficiency will increase visceral fat accumulation independently of total fat mass.
Interventions
- DRUG Hydrocortisone
- DIETARY_SUPPLEMENT Isocaloric Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2000-08 |
| Est. Completion | 2004-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00688987
The ClinicalTrials.gov registry entry for NCT00688987 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Hydrocortisone is the first listed.
NCT00688987 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00688987 about?
NCT00688987 is a clinical study titled "The Hypothalamic-Pituitary-Adrenal (HPA) Axis as an Effector System in Weight Regulation". Replacing glucocorticoid in a dose dependent manner (including doses within the physiological range) to subjects with adrenal insufficiency will increase visceral fat accumulation independently of total fat mass.
What is the current status of trial NCT00688987?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2000-08. Estimated completion is 2004-08.
What interventions are being tested in trial NCT00688987?
The interventions under investigation include: Hydrocortisone (DRUG), Isocaloric Diet (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00688987?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.